Introduction {#mjz004s1}
============

Pancreatic beta cells are specialized for the synthesis and secretion of sufficient insulin in response to blood glucose challenges. A well-developed endoplasmic reticulum (ER) ensures the effective production of insulin under physiological stimuli. However, when confronted with persistent metabolic stress, such as obesity, the rapidly increased demand of insulin secretion activates the unfolded protein response (UPR) to relieve ER stress ([@mjz004C9]; [@mjz004C17]). However, high ER stress induces beta cell dysfunction and apoptosis through sensors, such as the inositol-requiring enzyme 1 (IRE1), protein kinase-like ER kinase (PERK), and the activation of transcription factor 6 (ATF6) ([@mjz004C34]). The unique roles of IRE1α in beta cells include the promotion of differentiation, enhancement of postprandial proinsulin biosynthesis, adaptive proliferation, and anti-apoptosis upon ER stress ([@mjz004C25]; [@mjz004C24]; [@mjz004C43]). Upon activation, IRE1α initiates the non-conventional splicing of the mRNA encoding X-box-binding protein-1 (XBP1), which upregulates IRE1α target genes to mitigate ER stress ([@mjz004C42]). However, prolonged activation of IRE1α causes phosphorylation of the c-Jun N-terminal kinase (JNK) and increased expression of DNA-damage inducible transcript 3 (*Ddit3*, also known as *Chop*), which can lead to beta cell dysfunction and apoptosis ([@mjz004C5]; [@mjz004C6]).

New evidence increasingly indicates that the main contributor of beta cell loss in type 2 diabetic patients is dedifferentiation, rather than apoptosis, since beta cell failure can be partly and temporarily reversed by dietary or pharmacological interventions ([@mjz004C47]; [@mjz004C11]; [@mjz004C3]; [@mjz004C51]; [@mjz004C8]). Notably, remission of type 2 diabetes can be achieved by bariatric surgeries operated on diabetic patients with morbid obesity ([@mjz004C30]), which suggests that cellular loss of beta cells is not permanent. Chronic ER stress in diabetic settings causes gradual loss of beta cell-specific transcriptional factors, including PDX1, MAFA, and FOXO1 ([@mjz004C40]; [@mjz004C23]; [@mjz004C14]), and reoccurrence of endocrine progenitor markers, such as NGN3 and OCT4 ([@mjz004C47]). These changes stimulate beta cells to exit their mature state into a dedifferentiated state manifested by defective GSIS function, decreased insulin positive cells, and consequently lessened beta cell mass. [@mjz004C47] first confirmed that loss of beta cell mass is mostly due to beta cell dedifferentiation in diabetes and in the discussion part, they pointed that those dedifferentiated beta cells were 'selfish beta cells', since dedifferentiation could facilitate their survival. Direct evidence was found in type 1 diabetes, which showed that under inflammatory stress, a group of beta cells decreased their characteristics of mature beta cells but showed increased stem-like features to escape from T-cell-mediated death with an unknown mechanism ([@mjz004C39]).

Even though beta cell dedifferentiation has been proposed as an important mechanism of beta cell failure in type 2 diabetes ([@mjz004C47]; [@mjz004C22]), the underlying mechanism has not been clarified. Prior studies focused on finding evidence to support the theory that beta cell dedifferentiation exists in diabetic animals and patients ([@mjz004C47]; [@mjz004C52]). In later animal studies, lineage tracing experiments were widely utilized to track the fate of beta cells, which might revert to progenitor-like cells or transdifferentiate to glucagon-producing 'alpha-like' cells to confront chronic glucolipotoxicity ([@mjz004C47]; [@mjz004C3]). Recently, evidence drawn from type 2 diabetic patients has also supported the view that beta cells become dedifferentiated and convert to 'alpha-like' and 'delta-like' cells ([@mjz004C7]). However, the leading factors of beta cell dedifferentiation were still undetected. Further studies to uncover whether ER stress is contributed to beta cell dedifferentiation are needed. More specifically, the mechanisms that cause ER stress, such as how IRE1α induces beta cell survival, apoptosis, and dedifferentiation under ER stress conditions, are still unknown.

MicroRNAs (miRNAs) are endogenous noncoding RNAs (\~22 nucleotides) that regulate gene expression by binding to the 3′UTR of their target mRNAs to degrade and/or inhibit the mRNAs translation. These miRNAs target potentially hundreds of mRNAs and posttranscriptionally control complex cellular processes, such as proliferation, differentiation, and apoptosis ([@mjz004C4]; [@mjz004C21]; [@mjz004C10]). Our previous study demonstrated that *microRNA-24* (*miR-24*) was elevated in islets isolated from diabetic mice and in human islets, as well as MIN6 cells treated with palmitate---a factor known to induce beta cell ER stress. Ectopic expression of *miR-24* caused beta cell dysfunction and replicative deficiency by modulating two MODY gene expressions ([@mjz004C57]). *miR-24* elevation also resulted in an inhibitory effect on the translation of XBP1 and ATF4, which are two downstream effectors of two key branches of ER stress. In the present study, we tested the effect of *miR-24* on treatment with the ER stress activator thapsigargin (TG) and explored the potential mechanism by which beta cells avoid ER stress-induced apoptosis and undergo dedifferentiation.

Results {#mjz004s2}
=======

miR-24 alleviates ER stress-induced beta cell apoptosis while causing dysfunction via dedifferentiation {#mjz004s3}
-------------------------------------------------------------------------------------------------------

TG is a widely used ER stress activator that induces beta cell dysfunction and apoptosis by increasing cellular free Ca^2+^ levels. We assessed apoptosis of MIN6 cells after treatment with 1 μg/ml of TG at different time intervals. A Hoechst 33342 staining assay showed that the number of pycnotic nuclei significantly increased in a time-dependent manner ([Supplementary Figure S1A](#sup1){ref-type="supplementary-material"}). PARP1, an endogenous caspase 3 cleavage substrate, was also time-dependently cleaved in the presence of TG treatment ([Supplementary Figure S1B](#sup1){ref-type="supplementary-material"}). We then transfected MIN6 cell with pre-*miR-24* and evaluated the effects of TG. About 90% cells were successfully transfected verified by the fluorescently labeled pre-*miR-24* ([Supplementary Figure S1C](#sup1){ref-type="supplementary-material"}). Surprisingly, *miR-24*-overexpressed MIN6 cells were resistant to TG-induced apoptosis (Figure [1](#mjz004F1){ref-type="fig"}A and B) as well as palmitate-induced apoptosis ([Supplementary Figure S2](#sup1){ref-type="supplementary-material"}). The anti-apoptotic effect of *miR-24* was also reproduced in primary mouse islets ([Supplementary Figure S1D](#sup1){ref-type="supplementary-material"}; Figure [1](#mjz004F1){ref-type="fig"}C and D). Moreover, insulin content was preserved in these cells after exposure to high doses of TG, while no between-group alterations of insulin content were observed with low dosages (0.1 μg/ml) of TG (Figure [1](#mjz004F1){ref-type="fig"}E). We took advantage of this relatively low-dose TG and assessed GSIS function on *miR-24*-transfected MIN6 cells. Intriguingly, *miR-24* elevation and 0.1 μg/ml TG treatment synergistically impaired GSIS function in MIN6 cells (Figure [1](#mjz004F1){ref-type="fig"}F).

![*miR-24* inhibits TG-induced apoptosis and GSIS dysfunction. (**A**) MIN6 cells were transfected with pre-Neg or pre-*miR-24* for 48 h, treated with DMSO or TG (1 μg/ml) for 24 h, and then stained with Hoechst 33342. Scale bar, 40 μm. (**B**) Columns demonstrate the percentage of apoptotic cells in **A**. (**C**) Islets from 8-week-old C57BL6/J mice were transfected with pre-Neg or pre-*miR-24* for 72 h and then treated with DMSO or TG (1 μg/ml) for further 24 h. Tunel combined with insulin and Hoechst 33342 staining was performed. Scale bar, 50 μm. (**D**) Columns show the percentage of apoptotic cells in **C**. (**E**) MIN6 cells were transfected with pre-Neg (clear bar) or pre-*miR-24* (black bar) for 48 h, treated with DMSO or the indicated concentrations of TG (0.1, 0.5, or 1.0 μg/ml) for 12 h, and then the insulin content was detected. (**F**) The GSIS assay was performed after 48 h post-transfection and a further 12-h treatment with DMSO or 0.1 μg/ml TG. Insulin secretion in low glucose (clear bar) and high glucose (black bar) was measured. \**P* \< 0.05 and \*\**P* \< 0.01.](mjz004f01){#mjz004F1}

Also, elevation of *miR-24* increased gene expression levels of *Ngn3*, *Oct4*, and *Sox2*, which are known dedifferentiation markers of beta cells (Figure [2](#mjz004F2){ref-type="fig"}A). The level of NGN3 protein was also examined by western blot and immunofluorescence assays (Figure [2](#mjz004F2){ref-type="fig"}B--D). Ectopic elevation of *miR-24* inhibited expression of two *insulin* genes (Figure [2](#mjz004F2){ref-type="fig"}E) and changed dedifferentiation markers in primary isolated islets (Figure [2](#mjz004F2){ref-type="fig"}F). Although the expression level of *Sox2* was slightly decreased, those of *Ngn3* and *Sox9* were significantly increased (Figure [2](#mjz004F2){ref-type="fig"}F). Using islet immunofluorescence, we also found a higher expression of Ngn3 after 96 h post-transfection with *miR-24* (Figure [2](#mjz004F2){ref-type="fig"}G and H). The elevated expression of *Ngn3* suggests that beta cells dedifferentiate into proendocrine cells, while *Sox9* elevation means that they convert into pancreatic progenitor cells ([@mjz004C26]; [@mjz004C41]). *Sox2* overexpression indicates the pancreatic beta cells might return to pluripotent stem cells ([@mjz004C53]). Taken together, elevated *miR-24* prevented ER stress-induced beta cell apoptosis while accelerated beta cell dysfunction, thus leading to beta cell dedifferentiation under diabetic conditions.

![*miR-24* increases the expressions of dedifferentiation markers. MIN6 cells were transfected with pre-Neg (control) or pre-*miR-24* for 48 h, treated with DMSO for further 3 h or 6 h, and then expression levels of *Ngn3*, *Oct4*, and *Sox2* were analyzed. (**A**) The mRNA levels of *Ngn3*, *Oct4*, and *Sox2* were analyzed by qRT-PCR assay. *β-actin* was used as internal control. (**B**) The protein level of NGN3 was examined by western blot. β-tubulin was used as internal standard. (**C**) Grey density of **B**. (**D**) An immunofluorescence assay was used to detect protein levels and distribution of INS and NGN3. (**E** and **F**) Primary isolated islets were transfected with pre-Neg or pre-*miR-24* for 72 h, and then mRNA levels of *Mafa, Pdx1, Ins1, Ins2, Ngn3, Sox2*, and *Sox9* were detected by qRT-PCR. \**P* \< 0.05 and \*\**P* \< 0.01 vs. control. (**G**) Primary isolated islets were transfected with pre-Neg or pre-*miR-24* for 96 h. An immunofluorescence assay was used to detect protein levels and distribution of INS and NGN3. (**H**) The percentage of NGN3^+^ cells in islets of **G**. \**P* \< 0.05 vs. control.](mjz004f02){#mjz004F2}

miR-24 inhibits XBP1 and ATF4 pathways {#mjz004s4}
--------------------------------------

Considering the effects of *miR-24* on ER stress, we used Ingenuity Pathway Analysis (IPA), an integration and search tool for pathways analyses, to re-evaluate the data from the Affimatrix mRNA chip that were obtained previously. We found that both the XBP1 and ATF4 pathways were inhibited by *miR-24* overexpression in MIN6 cells as shown by clustering of expression levels of downstream genes (Figure [3](#mjz004F3){ref-type="fig"}A). Three ATF4 transcriptional target genes and seven XBP1-associated genes were validated by qRT-PCR (Figure [3](#mjz004F3){ref-type="fig"}B), suggesting their involvement in *miR-24*-modulated, ER stress-associated effects.

![*miR-24* inhibits XBP1 and ATF4 signaling. (**A**) Expression levels of ER stress-associated genes were reanalyzed based on the previous mRNA microarray data by IPA. (**B**) MIN6 cells were transfected with pre-Neg (control, clean bar) or pre-*miR-24* (black bar) for 48 h, and mRNA levels were analyzed by qRT-PCR assay. Data shown are mean ± SEMs and represent three separate experiments. *β-actin* was used as internal control. \*\**P* \< 0.01 vs. control.](mjz004f03){#mjz004F3}

Ire1α is a target of miR-24 {#mjz004s5}
---------------------------

To identify the direct targets of *miR-24*, Targetscan was used for target gene prediction. Since no conserved seed sequences were found on the 3′UTRs of either *Xbp1* and *Atf4*, the prediction work was then extended to their upstream regulators. *Ire1α*, *Perk*, *Atf6*, *and Erp29*, are related genes involved in XBP1 signaling. As shown in Figure [4](#mjz004F4){ref-type="fig"}A, the miRNA response elements (MRE) of *miR-24* were located on 3′UTR of *Ire1α* and *Erp29*. The gene expression levels of these three key branches and their main effectors were examined, and only *Xbp1*, *Chop*, and *Grp78* were modestly decreased. *Ire1α*, *Perk*, *Atf6*, and *Atf4* did not change with the expression of *miR-24* (Figure [4](#mjz004F4){ref-type="fig"}B). Next, the sequences containing wild-type (wt) and mutant (mt) *miR-24* MRE were subcloned into pmiR-REPORTOR. The luciferase activity assay showed that *miR-24* inhibited the activity of the wt-*Ire1α* construct when compared with a vector control, whereas no alteration was observed with the mt-*Ire1α* construct (Figure [4](#mjz004F4){ref-type="fig"}C). *miR-24* was also found to inhibit MRE from *Erp29* (Figure [4](#mjz004F4){ref-type="fig"}D) and *Pdi* ([Supplementary Figure S3A and B](#sup1){ref-type="supplementary-material"}).

![*miR-24* regulates *Ire1α* and *Erp29*. (**A**) The 3′UTR sequences of *Ire1α* and *Erp29* predicted to include *miR-24* MREs were aligned with *miR-24*, and both wt and mt sequences are listed. (**B**) MIN6 cells were transfected with pre-Neg (control, clean bar) or pre-*miR-24* (black bar) for 48 h, and mRNA levels were analyzed by qRT-PCR assay. *β-actin* was used as internal control. \**P* \< 0.05 and \*\**P* \< 0.01 vs. control. (**C**) MIN6 cells were co-transfected with pre-*miR-24* and Vector, wt-*Ire1α*, or mt-*Ire1α*; after 48 h, dual luciferase reporter activities were measured. \*\**P* \< 0.01 vs. Vector and ^\#\#^*P* \< 0.01 vs. wt-*Ire1α*. (**D**) MIN6 cells were co-transfected with pre-*miR-24* and Vector, wt-*Erp29*, or mt-*Erp29*; after 48 h, dual luciferase reporter activities were measured. \*\**P* \< 0.01 vs. Vector and ^\#\#^*P* \< 0.01 vs. wt-*Erp29*. (**E**) MIN6 cells were transfected with pre-Neg or pre-*miR-24* for 48 h and protein levels were analyzed by western blot. β-tubulin was used as internal standard.](mjz004f04){#mjz004F4}

Furthermore, *miR-24* overexpression significantly reduced the protein levels of pIRE1α, IRE1α, and ERP29 (Figure [4](#mjz004F4){ref-type="fig"}E). The gene expression and protein levels of PDI---a disulfide isomerase that catalyzes the formation, breakage, and rearrangement of disulfide bonds---were also significantly decreased by *miR-24* overexpression ([Supplementary Figure S3C and D](#sup1){ref-type="supplementary-material"}). Thus, we identified that the three ER-resident proteins, *Ire1α*, *Erp29*, and *Pdi*, were targets of *miR-24*.

Ire1α mediates the anti-apoptotic effect of miR-24 {#mjz004s6}
--------------------------------------------------

To further understand the role of *Ire1α* on *miR-2*4 mediated effects, MIN6 cells transfected with *miR-24* were treated short-term and long-term with TG. As shown in Figure [5](#mjz004F5){ref-type="fig"}A, short-term TG treatment significantly increased the phosphorylation of IRE1α. p-IRE1α was at the highest level after a 2-h treatment when the level of CHOP started to increase. The levels of both p-IRE1α and CHOP can be inhibited by *miR-24* overexpression.

![*miR-24* inhibits IRE1α/XBP1s signaling. (**A**--**D**) MIN6 cells were transfected with pre-Neg or pre-*miR-24* for 48 h. (**A** and **B**) Transfected cells were further treated with or without 1 μg/ml TG for indicated time and protein levels were analyzed by western blot. β-tubulin was used as internal standard. (**C**) A semi-quantitative RT-PCR assay was performed after a 3-h treatment with or without 1 μg/ml TG, and the PCR products were separated with a 3% agarose gel. *Xbp1* splicing efficiency was calculated as the ratio of the spliced *Xbp1* level divided by the total *Xbp1* level. (**D**) Transfected cells were treated with the indicated concentrations of TG for 3 h and protein level of XBP1s was determined. Relative XBP1s level was shown under the band. (**E**--**G**) MIN6 cells were transfected with si-NC or si-*Ire1α* for 48 h. (**E**) mRNA level of *Ire1α* was analyzed by qRT-PCR assay. *β-actin* was used as internal control. \*\**P* \< 0.01 vs. si-NC. (**F**) Protein level of IRE1α was analyzed by western blot. β-tubulin was used as internal standard. Grey density data are shown below. \*\**P* \< 0.01 vs. si-NC. (**G**) Transfected cells were further treated with or without 1 μg/ml TG for 24 h, and apoptotic cells were calculated by Hoechst33342 staining. (**H**) MIN6 cells were transfected with *Ire1α* or *Xbp1s* for 48 h and protein levels were measured. (**I**) MIN6 cells were co-transfected with the indicated plasmid and miRNA for 48 h, treated with (black bar) or without (clean bar) 1 μg/ml TG for an additional 16 h, and then apoptotic cells were counted. \**P* \< 0.05 and \*\**P* \< 0.01.](mjz004f05){#mjz004F5}

Meanwhile, the protein levels of ERP29 and PDI were unchanged by TG treatment, even though *miR-24* can decrease protein levels. Prolonged treatment with TG for 8 h can induce MIN6 cell apoptosis ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}); thus, *miR-24*-transfected cells were treated with TG for 6 and 12 h to assess the molecular alterations of the three key ER branches (Figure [5](#mjz004F5){ref-type="fig"}B). The decreased level of cleaved PARP1 at both timepoints showed the anti-apoptotic role of *miR-24* at the molecular level. Again, p-IRE1α, CHOP, and GRP78 levels were reduced by *miR-24* overexpression at 6 h. However, p-IRE1α was decreased to normal levels after a 12-h treatment with TG, by which time, the protein levels of CHOP and GRP78 remained high. No between-group alterations of ATF4 and p-eIF2α were discovered (Figure [5](#mjz004F5){ref-type="fig"}B), nor were there any alterations of other ER stress-associated molecules of interest ([Supplementary Figure S4](#sup1){ref-type="supplementary-material"}).

IRE1α modulates the gene expression level and splicing of *Xbp1* mRNA, and *miR-24* overexpression inhibited both unspliced-*Xbp1* (*Xbp1u*) and spliced-*Xbp1* (*Xbp1s*) mRNA levels (Figure [3](#mjz004F3){ref-type="fig"}B). In particular, TG provoked a high expression level of *Xbp1s* that was significantly inhibited in *miR-24*-transfected MIN6 cells (Figure [5](#mjz004F5){ref-type="fig"}C). The inhibitory effect of *miR-24* was confirmed by the XBP1s protein level (Figure [5](#mjz004F5){ref-type="fig"}D). Collectively, *miR-24* elevation inhibited IRE1α/XBP1 signaling at both basal and TG-stimulated levels.

To assess the role of IRE1α on *miR-24*-associated effects, siRNA interference of *Ire1α* was introduced. The interference efficiency was examined in both mRNA and protein levels (Figure [5](#mjz004F5){ref-type="fig"}E and F). Knockdown of *Ire1α* significantly inhibited the number of apoptotic cells induced by TG, mimicking the anti-apoptotic effect of *miR-24* (Figure [5](#mjz004F5){ref-type="fig"}G). In contrast, overexpression of *Ire1α* had no additional effect on TG-induced MIN6 cell apoptosis ([Supplementary Figure S5](#sup1){ref-type="supplementary-material"}). Notably, overexpression of either *Ire1α* or *Xbp1s* counteracted the anti-apoptotic effect of *miR-24* against TG exposure (Figure [5](#mjz004F5){ref-type="fig"}H and I). Taken together, these results demonstrate that elevated *miR-24* under metabolic stress could confer resistance to ER stress-induced apoptosis via inhibiting the IRE1α/XBP1 pathway.

miR-24 induces insulin secretion defect by targeting Mafa {#mjz004s7}
---------------------------------------------------------

The role of IRE1α on specialized beta cell functions was also examined. Knockdown of *Ire1α* inhibited insulin content and basal insulin secretion without altering glucose-stimulated insulin secretion ([Supplementary Figure S6A and B](#sup1){ref-type="supplementary-material"}). TG-induced GSIS defects could not be potentiated by *Ire1α*-knockdown ([Supplementary Figure S6C](#sup1){ref-type="supplementary-material"}). This suggested that *Ire1α* did not contribute to *miR-24*-excess-induced insulin secretion defects.

Beta cell-specific transcriptional factors, including MAFA, PDX1, NEUROD1, and HNF1α, are well-recognized factors contributing to ER stress-induced beta cell dysfunction. We previously reported that *miR-24* MREs were located on 3′UTR of *Neurod1*, *Hnf1α*, and *Pdx1*. *Mafa* was also identified as a target by the Targetscan software (Figure [6](#mjz004F6){ref-type="fig"}A). The regulatory role between *miR-24* and *Mafa* was confirmed by a luciferase activity assay (Figure [6](#mjz004F6){ref-type="fig"}B), as was the connection between *miR-24* and *Pdx1* (Figure [6](#mjz004F6){ref-type="fig"}C). The protein levels of MAFA, PDX1, NEUROD1, and HNF1α were significantly reduced by *miR-24* overexpression (Figure [6](#mjz004F6){ref-type="fig"}D). The above results showed that, in addition to the three previously reported transcriptional factors, *Mafa* was also a target of *miR-24*.

![*miR-24* targets *Mafa* and *Pdx1*. (**A**) 3′UTR sequences of *Mafa* and *Pdx1* predicted to include *miR-24* MREs were aligned with *miR-24*, and both wt and mt sequences were listed. (**B**) MIN6 cells were co-transfected with pre-*miR-24* and Vector, wt-*Mafa*, or mt-*Mafa*. After 48 h, dual luciferase reporter activities were measured. \*\**P* \< 0.01 vs. Vector and ^\#\#^*P* \< 0.01 vs. wt-*Mafa*. (**C**) MIN6 cells were co-transfected with pre-*miR-24* and Vector, wt-*Pdx1*, or mt-*Pdx1*. After 48 h, dual luciferase reporter activities were measured. \*\**P* \< 0.01 vs. Vector and ^\#\#^*P* \< 0.01 vs. wt-*Pdx1*. (**D**) MIN6 cells were transfected with pre-Neg or pre-*miR-24* for 48 h and protein levels were analyzed by western blot. β-tubulin was used as internal standard.](mjz004f06){#mjz004F6}

Next, mRNA and protein levels of these four transcriptional factors were sequentially examined after TG treatment. No significant alterations of their mRNA levels were detected (data not shown), but the protein level of MAFA rapidly declined after 4 h of TG treatment. In fact, the protein level was even affected by a low TG dose, while the other three transcriptional factors decreased later and were only affected by a high-dose TG treatment (Figure [7](#mjz004F7){ref-type="fig"}A and B).

![MAFA contributes to the *miR-24*-induced GSIS defect under ER stress condition. (**A**) MIN6 cells were treated with or without 0.1 μg/ml TG for the indicated times and protein levels were determined by western blot. (**B**) MIN6 cells were treated with the indicated concentrations of TG for 12 h, and protein levels were determined by western blot. (**C**) MIN6 cells were transfected with pre-Neg or pre-*miR-24* for 48 h and further treated with or without 0.1 μg/ml TG for 12 h when protein levels were analyzed by western blot. (**D** and **E**) MIN6 cells were co-transfected with the indicated miRNA and plasmid for 48 h and further treated with 0.1 μg/ml TG for 12 h. (**D**) Protein levels were analyzed by western blot. β-tubulin was used as internal standard. (**E**) GSIS assay was performed and relative insulin secretion levels were normalized by the Vector and pre-Neg group. \**P* \< 0.05 and \*\**P* \< 0.01.](mjz004f07){#mjz004F7}

Moreover, the protein level of MAFA exhibited the most obvious synergistic decrease in *miR-24*-transfected cells treated with TG (Figure [7](#mjz004F7){ref-type="fig"}C). PDX1 level also displayed a small degree of synergistic decline (Figure [7](#mjz004F7){ref-type="fig"}C). Afterwards, recoveries of MAFA and PDX1 by plasmid-based overexpression were performed (Figure [7](#mjz004F7){ref-type="fig"}D). Surprisingly, only *Mafa* overexpression could rescue the effects of elevated *miR-24* when combined with TG-treatment-induced GSIS defects (Figure [7](#mjz004F7){ref-type="fig"}E). Taken together, *miR-24* inhibits MAFA to guide the survived beta cells towards dysfunction under ER stress conditions.

Discussion {#mjz004s8}
==========

Our study explored the role of *miR-24* in regulating beta cell turnover under diabetic settings. Phenotypically, *miR-24* elevation was resistant to ER stress-induced apoptosis but at the price of inhibiting GSIS function, thus guiding beta cell survival from ER stress towards dedifferentiation. Mechanistically, *miR-24* targeted *Ire1α* to protect beta cells from ER stress-induced apoptosis. In contrast, *miR-24* also targeted *Mafa* to induce beta cell dysfunction and dedifferentiation. These factors represent a possible mechanism through which beta cell loss in type 2 diabetes could be attributed to dedifferentiation rather than apoptosis.

It is widely appreciated that pancreatic beta cells experience dramatic ER stress in type 2 diabetes because of the increased insulin secretion demand that is primarily caused by hyperglycemia and obesity ([@mjz004C12]; [@mjz004C2]). We have previously reported that *miR-24* abundance in pancreatic islets could be significantly elevated when confronting an ER stress condition. Ectopic overexpression of *miR-24* resulted in inhibition of both insulin secretion and beta cell growth by modulating *Neurod1*-MODY and *Hnf1α*-MODY gene expression ([@mjz004C57]). It seems that the elevated *miR-24* initiates protective processes to avoid excess insulin secretion and relieve the severe metabolic burden imposed on the beta cells. The efforts made by *miR-24* are likely to antagonize ER stress conditions by reducing insulin biosynthesis and secretion, despite it possibly not having any benefit on maintaining blood glucose homeostasis in diabetic settings. This provides indirect evidence to support the theory that *miR-24* can mitigate ER stress conditions.

Therefore, we reanalyzed the data from the mRNA gene chip analysis that previously reported on to search for any direct connection between *miR-24* and ER stress. Surprisingly, downstream effectors of both XBP1 and ATF4 were significantly decreased by *miR-24* elevation, suggesting a potential inhibitory role of *miR-24* on ER stress. By using software prediction, luciferase activity assay, and western blotting, we found that *Ire1α* is a target gene of *miR-24.* This provides a direct link between *miR-24* and ER stress through IRE1α.

IRE1α plays an important role in secretory cells, such as pancreatic beta cells and plasma cells ([@mjz004C20]; [@mjz004C56]). Physical activation of IRE1α by transient exposure to high glucose positively regulates proinsulin biosynthesis ([@mjz004C25]). Alternatively, severe activation of IRE1α caused by a chronic high-glucose and ER stress inducer leads to ER-resident mRNA decay, such as *insulin*, thus causing defective insulin biosynthesis, beta cell dysfunction, and apoptosis ([@mjz004C19]; [@mjz004C55]; [@mjz004C56]).

The divergent role of IRE1α on insulin biosynthesis relies on the ability of autophosphorylation-coupled RNase activity. Acute exposure to high glucose only initiates an increase in autophosphorylation of IRE1α ([@mjz004C25]). In contrast, chronic exposure of beta cells to high glucose levels provokes both phosphorylation and RNase activities in IRE1α, thereby causing adaptive splicing of the *Xbp1* mRNA to promote survival ([@mjz004C25]; [@mjz004C6]), but otherwise enforcing endonucleolytic decay of many ER-resident mRNAs, including *insulin* and ER chaperones to promote dysfunction and apoptosis ([@mjz004C18]; [@mjz004C55]; [@mjz004C56]).

Reports have shown that IRE1α kinase activation modes control alternate RNase outputs to determine divergent cell fates ([@mjz004C16]; [@mjz004C48]). Nevertheless, allosteric inhibition of the IRE1α RNase by KIRA6 could protect beta cells from severe ER stress-induced dysfunction, growth inhibition, and apoptosis *in vitro* and *in vivo* ([@mjz004C13]). Moreover, deletion of *Ire1α* or reduction of IRE1α through RNAi also repressed ER-localized mRNA decay during ER stress. This suggests that the protein level of IRE1α directly controls its RNase activity ([@mjz004C16]; [@mjz004C44]).

As a verified target, our research showed that elevation of *miR-24* reduced the protein and phosphorylation levels of IRE1α under both basic and TG-imposed ER stress conditions. The inactivation of IRE1α by *miR-24* caused a decrease in insulin secretion but preserved insulin biosynthesis in beta cells during ER stress situations, perfectly representing the physical and pathological characteristics of IRE1α. Thus, the ER stress-induced *miR-24* has a negative feedback on ER stress conditions in pancreatic beta cells.

Overactivation of IRE1α promotes cell apoptosis through the JNK and CHOP pathways. Reports have shown that IRE1α recruits TRAF2 to cause ASK1 activation under ER stress conditions ([@mjz004C49]; [@mjz004C33]). Activated ASK1 mediates JNK activation and results in neuronal cell apoptosis ([@mjz004C33]). However, their roles in ER stress-mediated beta cell apoptosis remain unclear. In our observations, the phosphorylation of JNK only increased after treatment with TG for 8 h when the apoptosis of beta cells had already occurred at an elevated level. This helped us rule out JNK for further investigation.

CHOP is an important component to ER stress-mediated apoptosis ([@mjz004C36]). Deletion of CHOP promotes beta cell survival and improves beta cell function in the Akita diabetes mouse model, which expresses a mutant (C96Y) proinsulin that is unable to complete oxidative folding and thus causes chronic ER stress ([@mjz004C35]). According to our results, the protein level of CHOP started to increase at 1 h and continued to climb to its peak at 6 h of treatment with TG. Moreover, elevated *miR-24* inhibited the TG-induced CHOP increase, suggesting the anti-apoptotic role of *miR-24* is commanded by an IRE1α/CHOP pathway. It is well accepted that CHOP is primarily regulated by the PERK/ATF4 pathway ([@mjz004C38]). However, the ATF4 level was not be inhibited by *miR-24*. We speculate that CHOP might also be modulated by IRE1α, since the downstream effectors of three ER branches are indistinguishable under severe ER stress ([@mjz004C46]).

The identification of CHOP as a downstream effector of IRE1α does not rule out the contribution of XBP1s in ER stress-induced apoptosis. Considerable evidence indicates that the transcription factor, XBP1s, drives the expression of ER chaperones and components of the ER-associated degradation (ERAD) to restore ER homeostasis ([@mjz004C15]; [@mjz004C54]; [@mjz004C45]). However, overexpression of XBP1s counteracted the anti-apoptotic effect of *miR-24*, which suggests that XBP1s is a proapoptotic molecule under irremediable ER stress conditions in pancreatic beta cells.

Consistent with our data, [@mjz004C1] reported that sustained production of XBP1s, but not XBP1u, promotes pancreatic beta cell dysfunction and apoptosis. These impairments engage with beta cell-specific molecules, such as insulin, PDX1, and MAFA, thus declaring a unique role for XBP1s in beta cell apoptosis. Nevertheless, mild ER stress could augment the proinflammatory effect of IL-1β through the IRE1α--XBP1s pathway in pancreatic beta cells ([@mjz004C28]).

Although *miR-24* promoted beta cell survival from ER stress-induced apoptosis and inhibited *insulin* mRNA degradation, the GSIS function was somehow synergistically restrained by *miR-24* elevation and TG exposure, thereby causing beta cell dedifferentiation. To solve this problem, we identified the maturation factors, MAFA and PDX1, as two additional targets of *miR-24*. Protein levels of both MAFA and PDX1 were reduced by TG in dose- and time-dependent manners. The emergence of MAFA reduction started at 4 h and could be synergistically decreased by TG treatment, which indicates its special role. The *in vitro* phenotype of beta cell dedifferentiation induced by increased *miR-24* could only be detected by DMSO pre-treatment, since DMSO itself can promote differentiation ([@mjz004C37]). This could also explain why those dedifferentiation markers were not elevated much in isolated primary mouse islets compared to MIN6 cells, which have not completed development and contain other pancreatic endocrine hormones ([@mjz004C31]). Using islets immunofluorescence of *Ngn3*, we found those dedifferentiated cells were located in the margin of islets, a pancreatic neogenic niche with plasticity in which alpha cells could transdifferentiate into beta cells ([@mjz004C50]). Cells in this niche have dedifferentiation and transdifferentiation potentials; so, we speculate that early dedifferentiation occurs from this location.

Indeed, overexpression of MAFA, but not PDX1, effectively rescued TG-induced GSIS defects and recovered insulin-positive cells. *Mafa* is critical for the homeostasis of mature beta cells and regulates cell plasticity ([@mjz004C32]). *Mafa* KO mice promote beta cell dedifferentiation, while overexpression of *Mafa* preserves beta cells and improves hyperglycemia in db/db diabetic mice ([@mjz004C27]; [@mjz004C32]). Our results support the same conclusion: that the transcription factor, MAFA, is important for maintaining beta cell identity in diabetic settings.

In conclusion, our investigation revealed that the ER stress effector *miR-24* could counteract ER stress-induced apoptosis at the cost of defective GSIS function. The anti-apoptotic capacity of *miR-24* provided a favorable explanation for the low detection of apoptosis rates in islets from type 2 diabetic patients and rodent animals, despite the presence of severe insulin defects. Our study strongly supports the theory that beta cell dedifferentiation is a dominant contributor to beta cell loss in type 2 diabetes. Once the hyperglycemia controls and the ER stress conditions remit, inhibition of *miR-24* might be an attractive therapeutic approach to treating diabetes.

Materials and methods {#mjz004s9}
=====================

Materials {#mjz004s10}
---------

See [Supplementary Methods](#sup1){ref-type="supplementary-material"}.

Cell culture {#mjz004s11}
------------

Cells of the MIN6, a mouse pancreatic beta cell line, were cultured in DMEM with 15% FBS, 100 U/ml penicillin, 100 μg/ml streptomycin, 10 mM HEPES, and 50 μM β-mercaptoethanol (Sigma-Aldrich). The cells were incubated at 37°C in a suitable atmosphere containing 95% O~2~ and 5% CO~2~. TG or DMSO (Sigma-Aldrich) was added to the appropriate experiments for the indicated time and at the indicated dose.

Pancreatic islet isolation {#mjz004s12}
--------------------------

Male 8-week-old C57BL6/J mice were purchased from Nanjing Medical University Laboratory Animal Center. Islet isolation and culturing methods were performed as previously described ([@mjz004C57]). Isolated islets were equilibrated in RPMI 1640 containing 11.1 mM glucose with 10% FBS, 10 mM HEPES, 100 U/ml penicillin, and 100 μg/ml streptomycin overnight. The cells were transfected with pre-*miR-24* or the pre-Negative control (pre-Neg) (Ambion) using Lipofectamine 2000 (Invitrogen) for 72 h, incubated with 1 μg/ml TG or DMSO for 24 h, and then fixed with 4% paraformaldehyde before use in further experiments. All animal studies were performed according to guidelines established by the Research Animal Care Committee of Nanjing Medical University.

Plasmid construction {#mjz004s13}
--------------------

The mouse expression plasmids, pcDNA3.1-*Xbp1s* and pCMV5-flag-*Ire1α*, were gifts from Prof. Yong Liu (Wuhan University) ([@mjz004C58]). The wild-type (wt) and mutant (mt) 3′UTR-luciferase constructs of mouse *Ire1α*, *Erp29*, *Mafa*, and *Pdx1* were generated as previously described and inserted into the pMIR-REPORT luciferase vector (Ambion) between the *Hin*dIII and *Spe*I cutting sites ([@mjz004C57]). The full-length coding region sequences of mouse *Pdx1* and *Mafa* were inserted into pCMV5-flag vector. All constructs were confirmed by sequencing. The primer sequences are shown in [Supplementary Table S1](#sup1){ref-type="supplementary-material"}.

Transient transfection and luciferase reporter assay {#mjz004s14}
----------------------------------------------------

MIN6 cells were cultured and transfected with luciferase reporter plasmids or overexpression plasmids as well as pre-*miR-24* or pre-Neg using Lipofectamine 2000 according to the manufacturer's instructions. Luciferase activities were measured 48 h after transfection with a dual-luciferase reporter assay system (Promega) and normalized to Renilla activity expressed with the PRL-SV40 plasmid (Promega).

Cell apoptosis assay {#mjz004s15}
--------------------

After different treatments, MIN6 cells were stained with Hoechst 33342 (Sigma-Aldrich) for 10 min at room temperature, washed with PBS, and then observed using a fluorescence microscope (Imager A1, Zeiss). All the cell nuclei were stained with a blue color. Cells with high blue fluorescence and fragmented nuclei were considered to be apoptotic, while weak blue signal indicated live cells. Images were obtained in random fields, and quantification of apoptotic cells was determined for at least 2000 cells in eight fields for each well. Apoptotic cells in primary islets were measured using a Tunel kit (Boster) and performed according to the manufacturer's instructions.

Glucose-stimulated insulin secretion assay {#mjz004s16}
------------------------------------------

MIN6 cells were transfected with pre-Neg or pre-*miR-24* and incubated with DMSO or TG. The cell culture medium was refreshed 12 h before initiating this assay to diminish the influence of the insulin accumulated in the cell supernatant. MIN6 cells were then pre-incubated for 1 h in KRBH buffer supplemented with 2 mM glucose and 1 g/L bovine serum albumin (BSA). Subsequently, the cells were incubated for 1 h in KRBH containing basal glucose (2 mM) or stimulatory glucose (20 mM). The supernatants were collected and frozen at −80°C for subsequent measurement of insulin concentration, and whole-cell insulin contents were extracted using an acid-ethanol solution (0.15 M HCL in 75% ethanol in H~2~O) overnight at 4°C. The collected supernatants were measured by radioimmunoassay (RIA) as previously described ([@mjz004C57]). Insulin content and glucose-stimulated insulin secretion were normalized to the total protein concentration.

RNA extraction and quantitative real-time PCR {#mjz004s17}
---------------------------------------------

Total RNA was extracted using Trizol reagent (Invitrogen) according to the manufacturer's protocol. The reverse transcriptions of miRNA and mRNA were performed as previously described ([@mjz004C57]). Quantitative real-time PCR was performed using the SYBR Green PCR Master Mix and Roche Lightcycle480 II Sequence Detection System (Roche Diagnostics). *U6* and *β-actin* were used to normalize miRNAs and mRNA, respectively. Sequences of the primers used here are available in [Supplementary Table S2](#sup1){ref-type="supplementary-material"}.

For semi-quantitative detective of spliced and un-spliced *Xbp1*, the following primers were used: forward, AAACAGAGTAGCAGCGCAGACTGC; reverse, TCCTTCTGGGTAGACCTCTGGGAG. PCR products were resolved on 3% agarose gels. *β-actin* was used as an internal control. The size difference between spliced and un-spliced *Xbp1* is 26 nucleotides.

Western blot analysis {#mjz004s18}
---------------------

After culturing and transfecting as described above, MIN6 cells were lysed with ice-cold lysis buffer (50 mM Tris-HCL, pH 7.4, 1% NP-40, 150 mM NaCl, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride). After protein content determination, western blotting was performed as previously described ([@mjz004C57]). See [Supplementary Methods](#sup1){ref-type="supplementary-material"} for more details.

Immunofluorescence {#mjz004s19}
------------------

MIN6 cells were grown on coverslips in 24-well plates, cultured, and transfected. Islets were cultured and transfected after isolation. Cells or islets were then fixed with 4% paraformaldehyde and blocked with 1 g/L BSA for 30 min. Cells or islets were incubated overnight in 4°C with a rabbit-anti Ngn3 antibody (ThermoFisher) that had been diluted 1:20 and further stained with an Alexa Fluor 594 AffiniPure Donkey anti-Rabbit IgG (YEASEN) in 37°C for 1 h. After that, cells or islets were co-stained with an goat-anti Insulin antibody (Santa Cruz) diluted 1:100 in 37°C for 1.5 h and then an Alexa Fluor 488 AffiniPure Donkey anti-Goat IgG (YEASEN) in 37°C for 1 h. All the antibodies were diluted with 1% BSA. Nuclei were stained with Hoechst 33342 and then observed by confocal microscopy (FV1200, Olympus).

Statistical analysis {#mjz004s20}
--------------------

Data are expressed as the mean ± SEM. *P-*values were calculated with a Student's two-tail *t*-test, and *P* \< 0.05 was considered to be significant.
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